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cell differentiation into cardiomyocytes
High glucose inhibits ES cell cardiogenesis
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Abstract
Background: Babies born to mothers with pregestational diabetes have a high risk for congenital heart defects
(CHD). Embryonic stem cells (ESCs) are excellent in vitro models for studying the effect of high glucose on cardiac
lineage specification because ESCs can be differentiated into cardiomyocytes. ESC maintenance and differentiation
are currently performed under high glucose conditions, whose adverse effects have never been clarified.
Method: We investigated the effect of high glucose on cardiomyocyte differentiation from a well-characterized ESC
line, E14, derived from mouse blastocysts. E14 cells maintained under high glucose (25 mM) failed to generate any
beating cardiomyocytes using the hanging-drop embryonic body method. We created a glucose-responsive E14
cell line (GR-E14) through a graduated low glucose adaptation. The expression of stem cell markers was similar in
the parent E14 cells and the GR-E14 cells.
Results: Glucose transporter 2 gene was increased in GR-E14 cells. When GR-E14 cells were differentiated into
cardiomyocytes under low (5 mM) or high (25 mM) glucose conditions, high glucose significantly delayed the
appearance and reduced the number of TNNT2 (Troponin T Type 2)-positive contracting cardiomyocytes. High
glucose suppressed the expression of precardiac mesoderm markers, cardiac transcription factors, mature
cardiomyocyte markers, and potassium channel proteins. High glucose impaired the functionality of ESC-derived
cardiomyocytes by suppressing the frequencies of Ca2+ wave and contraction.
Conclusions: Our findings suggest that high glucose inhibits ESC cardiogenesis by suppressing key developmental
genes essential for the cardiac program.
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Background
Nearly 2% of all pregnancies are affected by pregesta-
tional diabetes [1]. Infants from pregestational diabetic
mothers have a greater risk of structural birth defects in-
cluding congenital heart defects (CHDs) than those from
nondiabetic mothers [2]. CHDs are the most common
congenital anomalies occurring in approximately 4 to 10
per 1000 live births [3]. Our previous studies have
shown that pregestational diabetes induces oxidative
stress and activates pro-apoptotic kinase signaling lead-
ing to endoplasmic reticulum stress, impaired cell prolif-
eration, and apoptosis, which cause defective heart
formation [4–12]. Additionally, maternal diabetes re-
presses the expression of transcription factors that are
essential for cardiac lineage specification [5, 8, 9, 13],
suggesting that maternal diabetes adversely impacts
cardiogenesis during early embryonic development. The
objective of the present study is to study the effect of
high glucose on ESC differentiation into cardiomyocytes.
Pluripotent embryonic stem (ES) cells, derived from
the preimplantation embryo, can differentiate into deriv-
atives of all three primary germ layers [14]. Since the
first mouse and human ES cells were successfully iso-
lated from blastocysts [15, 16], they have been widely
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used for the generation of differentiated cells including
cardiomyocytes [17–20]. The ES differentiation process
to cardiomyocytes is a unique in vitro model for study-
ing the effect of high glucose on early cardiac lineage
specification and cardiomyocyte maturation. Several pro-
cedures have been reported for cardiomyocyte differenti-
ation from ES cells with different efficiencies [21–24].
ES differentiation procedures using kinase inhibitors or
inhibitors of the Wnt signaling achieve a high yield of
positive cardiomyocytes [25]; however, these inhibitors
may adversely impact the function of resultant cardio-
myocytes. Using the embryoid body (EB) hanging-drop
method, a low number of contracting cardiomyocytes
can be generated in regular medium without small mole-
cules and kinase inhibitor treatment. Therefore, we used
this method in our experiment.
Essentially, all ES cell differentiation procedures have
been performed under high glucose conditions (25 mM),
which is not comparable to physiological concentration
of glucose (5 mM) [26]. ES cell differentiation into cardi-
omyocytes under physiological glucose conditions reca-
pitulates the cardiac cell lineage specification during
early embryogenesis. In the present study, the mouse ES
cell line (E14), initially cultured under high glucose, was
gradually adapted into low glucose conditions and even-
tually maintained under 5 mM glucose conditions. The
stemness of these adapted E14 cells, which were glucose
responsive (GR-E14 cells), was not different with that of
the parent E14 cells. Using the EB hanging-drop method,
GR-E14 cells effectively generated contracting cardio-
myocytes (70%) under physiological glucose conditions.
High glucose significantly delayed cardiogenesis and
suppressed gene expression pertinent to cardiac lineage
specification. Our study provides evidence that glucose
is a crucial effector in ES cardiogenesis.
Methods
mESCs maintenance
The E14 mESC line and the D3 cell line derived from
blastocysts [27] were purchased from ATCC (Manassas,
VA, USA) and maintained in feeder-free conditions ac-
cording to the ATCC instructions. Briefly, E14 mESCs
were plated on 6-well culture plates coated with 0.1%
gelatin in DMEM medium (DMEM, 15% ES quality FBS,
1% NEAA, 1% glutamine, 1% β-mercaptolethanol, 1000
U/ml LIF, 1% antibiotics). Medium was changed daily.
Regular subculture was performed by a ratio of 1 to 6.
E14 mECS line maintained under 25 mM glucose
medium was initially transferred to a medium with 11.1
mM glucose for eight passages and subsequently 8.3
mM glucose for another eight passages. The resulting
E14 cells were then switched into medium with the
physiological glucose concentration (5 mM) for four
passages. The same protocol was applied to the D3
mESC line. All of the experiments in this study began
with E14 mES cells (called GR-E14) from passage 20
under 5 mM glucose conditions.
E14 cell differentiation to cardiomyocytes
Cardiomyocytes were differentiated from GR-E14 cells
via the hanging-drop method [28] in differentiation
medium containing 5 or 25 mM glucose (25% DMEM,
25% F12 medium, 50% neurobasal medium, 1% N2, 2%
B27, 1% NEAA, 1% glutamine, 1% β-mercaptolethanol,
1% antibiotics). GR-E14 cells at 80% confluence were
dissociated with Accutase solution (Life Technologies,
Grand Island, NY, USA) at 37 °C for 7 minutes, and the
collected cells were adjusted to a concentration of 3.3 ×
104 cells/ml. Fifty drops of 30 μl cell suspension (1000
cells/drop) were seeded into the lid of a 10-cm petri dish
with 15 ml PBS for EB formation for 3 days followed by
suspension culture in a petri dish for an additional 2
days in medium containing 5 mM or 25 mM glucose.
After 5 days, the formed EBs were transferred into 0.1%
gelatin-coated 6-well culture plates and cultured for an
additional 7 to 9 days for cardiogenesis. Contracting EBs
and cell colonies were monitored daily under micros-
copy. For counting the contracting EB number, 50 EBs
per group were plated on a 10-cm culture dish coated
with 0.1% gelatin and were monitored daily under
microscopy.
Fluorescence-activated cell sorting (FACS)
Cells at differentiation day 6, 8, and 10 were dissociated
into single cells by Trypsin-EDTA and transferred to
flow cytometry tubes (BD Biosciences, San Jose, CA,
USA) followed by fixation and permeabilization using
the BD Cytofix/Cytoperm Kit (BD Biosciences, San Jose,
CA, USA) with addition of 1:200 mouse anti-Tnnt2 anti-
body (Sigma-Aldrich, St. Louis, MO, USA) for 30 minutes
at room temperature. Secondary antibody staining was
performed in 1:1000 Alexa Fluor 488 goat anti-mouse
IgG1 for 30 minutes. Cells were analyzed using the FACS-
Canto II and the FACSDiva software (BD Biosciences, San
Jose, CA, USA). Data were analyzed using the FlowJo 10.1
software (FlowJo, LLC, Ashland, OR, USA).
RNA isolation and real-time PCR
RNA was isolated with Trizol reagent (Invitrogen, Grand
Island, NY, USA) from cells at different differentiation
days according to the manufacturer’s instruction. cDNAs
were synthesized from 1 μg total RNA by the Quantitect
Reverse Transcription Kit (Qiagen, Valencia, CA, USA).
The real-time qPCR for Oct4, Sox2, Lin28, Klf2, T,
Glut2, Mixl1, Gata4, Tbx5, Nkx2.5, Mef2c, TnnT2, SER-
CA2A, RYR2, Hcn1-4, and Kcn1 were performed by the
Rt2 Sybr Green Rox qPCR Mastermix (Qiagen, Valencia,
CA, USA) in the StepOnePlus system (Applied
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Biosystems, Grand Island, NY, USA). Primer sequences
for qPCR are listed in the Additional file 1: Table S1.
Western blotting
A total of 30–50 μg protein from cells at differentiation
day 9 was extracted using the cell lysis buffer (Cat#
9803, Cell Signaling, Danvers, MA, USA) containing a
1% protease inhibitor cocktail (Sigma-Aldrich, St. Louis,
MO, USA), 1% PMSF, 2% sodium fluoride, and 2% so-
dium orthovanadate. Immunobilon-P (EMD Milllipore,
Billerica, MA, USA) membranes were used for immuno-
blotting. Membranes were sequentially exposed to
mouse anti-GATA4 (1:1000, Origene, Rockville, MD,
USA), rabbit anti-TBX5 (1:1000, Life Technologies,
Grand Island, NY, USA), mouse anti-MEF2C (1:1000,
Thermo Fisher Scientific, Waltham, MA, USA), rabbit
anti-KCN1 (1:1000, Prosci Inc., San Diego, CA, USA)
and rabbit anti-TnnT2 (1:1000, Origene, Rockville, MD,
USA) overnight followed by incubation of goat anti-
rabbit IgG or goat anti-mouse IgG conjugated with HRP
(1:10,000, Jackson ImmunoResearch Laboratories, West
Grove, PA, USA) for 4 hours. Signals were detected
using the SuperSignal West Femto Maximum Sensitivity
Substrate Kit (Pierce Biotechnology, Rockford, IL, USA)
and chemiluminescence emitted from the bands was dir-
ectly captured using the UVP Bioimage EC3 system.
Densitometric analyses of chemiluminescence signals
were performed using the VisionWorks LS software
(UVP, Upland, CA, USA).
Immunofluorescence
EBs were plated onto 0.1% gelatin-coated chamber slides
(Thermo Fisher Scientific, Waltham, MA, USA) in high
or low glucose medium. At differentiated day 7 to 9,
cells were fixed by 4% paraformaldehyde for 10 minutes
at room temperature followed by permeabilization with
0.05% TritonX-100 for 10 minutes. Samples were
blocked for 1 hour with 10% heat-inactivated donkey
serum in PBS and incubated with the following anti-
bodies: TNNT2 (1:200, Origene, Rockville, MD, USA),
NKX2.5 (1:200, Sigma-Aldrich, St. Louis, MO, USA),
and HCN1 (1:200, Sigma-Aldrich, St. Louis, MO, USA),
overnight at 4 °C. After washing with PBS three times,
cells were incubated with a Cy3-conjugated secondary
antibody (diluted 1:1000) at room temperature for 4
hours followed by incubation with DAPI for 10 minutes
and mounted with aqueous mounting medium. Fluores-
cence image were taken on Nikon H600L microscope
(Nikon, Tokyo, Japan) with the IPLab imaging system
(Scientific Instrument Company, San Diego, CA, USA).
Ca2+ imaging
Differentiated EB in low or high glucose conditions were
placed on gelatin-coated chamber slides (Lab-Tek,
Thermo Fisher Scientific, Waltham, MA, USA) for Ca2+
imaging based on a previously described protocol [29].
ES-derived cardiomyocytes at day 9 were loaded with 5
μM fluo 4-AM (Thermo Fisher Scientific, Waltham,
MA, USA) for 20 minutes at room temperature and
replaced with normal Tyrode’s solution containing (in
mM) 140 NaCl, 10 Hepes, 0.5 MgCl2, 0.33 NaHPO4,
5.5 glucose, 1.8 CaCl2, and 5 KCl (pH 7.4). Confocal
imaging (Zeiss LSM-510; Carl Zeiss, Oberkochen,
Germany) was used to monitor Ca2+ signals using a
line scan method for 10,000 time at 1.93 msec per
line. Data were analyzed using ImageJ (NIH, Bethesda,
MD, USA).
Statistical analysis
Data was analyzed by the Sigmaplot 12.5 software (Systat
Software Inc, San Jose, CA, USA). Experiments were re-
peated independently three times. Data are presented as
mean ± SD. Statistical differences were evaluated using
one-way analysis of variance (ANOVA) followed by the
Tukey test.
Results
E14 cells adapted to physiological glucose concentrations
retain stemness and have a high expression of glucose
transporter 2
Like most ES cell lines, the E14 cell is maintained under
high glucose conditions (25 mM glucose). In order to as-
sess the effect of high glucose on ES cell differentiation,
it is essential to establish an ES cell line which is adapted
to the physiological glucose concentration (5 mM). Here,
we showed a simple and cost-saving method for the es-
tablishment of an E14 cell line adapted to physiological
glucose conditions by gradually lowering the glucose
concentration to 5 mM in culture medium as described
in the “Methods” section. The expression of pluripotent
markers, OCT4, SOX2, LIN28, and KLF2, in the
glucose-adapted E14 cell line was similar to that in the
parent E14 cell line that was maintained under high glu-
cose conditions (Fig. 1a). It has been shown that an ES
cell line established under low glucose conditions ex-
presses higher levels of glucose transporter 2 (Glut2)
comparing with those in an ES cell line cultured in high
glucose [30]. Glut2 expression was significantly higher in
the low glucose-adapted E14 cells than in the parent E14
cells (Fig. 1b), suggesting that the low glucose-adapted
E14 cells are glucose responsive (GR-E14 cells). Embry-
oid bodies derived from GR-E14 cells had a similar ex-
pression of SOX1, Brachyury (T), and AFP as that in the
parent E14 cells (Fig. 1c), indicating that the GR-E14
cells retained the capability of differentiation into all
three primary germ layers.
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High glucose suppresses the differentiation of GR-E14
cells into contracting cardiomyocytes
CHDs frequently occur in babies whose mothers have
diabetes [31]. Previous studies have demonstrated that
the high glucose of diabetes suppresses gene expression
related to apoptosis, proliferation, and migration in the
developing heart [13, 31, 32]. However, early develop-
ment events such as the ontogeny of cardiomyocytes
from ES cells may be affected by high glucose and thus
contribute to the etiology of CHD formation in diabetic
pregnancies. We hypothesize that high glucose sup-
presses ES cardiogenesis. To test this hypothesis, embry-
oid bodies (EBs) were formed for 5 days with the
hanging-drop method prior to further differentiation
into cardiomyocytes [33, 34], (Fig. 2a). When the parent
E14 cells, which are accustomed to high glucose, were
used for differentiation into cardiomyocytes under either
low glucose (5 mM) or high glucose (25 mM) condi-
tions, very few EBs derived from these cells could attach
to surfaces of culture plates coated with 0.1% gelatin at
the first day of differentiation (Fig. 2b). Even after 5 days,
only few EBs attached to culture plates (Fig. 2c), and
none of these attached EBs could differentiate to con-
tracting cardiomyocytes (data not included). In contrast,
most of the EBs derived from GR-E14 cells (93.3 ± 4.6%
in 5 mM glucose and 74.0 ± 4.0% in 25 mM glucose) at-
tached to culture plates at the first day of differentiation
and remained attached at high numbers in day 5 (Fig. 2b
and c). Therefore, we only focused on GR-E14 for fur-
ther experiments to assess the effect of high glucose.
For the differentiation of GR-E14 cells, contracting
EBs or cardiomyocytes appeared at day 6 in 5 mM glu-
cose and at day 8 in high glucose (25 mM) medium, re-
spectively (Fig. 2d). Thus, high glucose delayed GR-E14
cell cardiogenesis for 2 days (Fig. 2d). Whereas 70.0 ±
4.0% of the EBs were differentiated into contracting car-
diomyocytes in 5 mM glucose at day 10, only 14.7 ± 1.2%
contracting EBs were obtained under high glucose (25
mM) conditions (Fig. 2d).
The contracting colony number in 5 mM glucose at
day 8 of differentiation was significantly higher than that
in high glucose (Fig. 2e). At day 10 of differentiation, the
contracting colony number in 5 mM glucose (109.7 ±
10.2) was significantly higher than that under high glu-
cose condition (29.0 ± 4.0), (P < 0.01) (Fig. 2e). Moreover,
the percentage of contracting colonies in 5 mM glucose
achieved 5.53 ± 1.35% at day 6. However, it took 10 days
to achieve a similar contracting colonies ratio (4.83 ±
0.67%) in 25 mM glucose (Fig. 2f ). Furthermore, the
contracting frequency of contracting colonies in 5 mM
glucose was significantly higher than that in 25 mM glu-
cose at day 10 of differentiation (Fig. 2g and Additional
file 2: Video 1 and Additional file 3: Video 2).
To further determine if cardiogenesis was affected by
high glucose, FACS was performed to detect TNNT2




Fig. 1 Characteristics of parent E14 cells and the GR-E14 cells adapted to low glucose. a mRNA levels of pluripotent markers, OCT4, SOX2, KLF2,
and LIN28, in parent E14 cells and E14 cells adapted to low glucose (GR-E14 cells). b Glut2 mRNA levels in GR-E14 and parent E14 cells. c mRNA
levels of ectoderm marker SOX1, mesoderm marker T, and endoderm marker AFP in EBs. E14 E14 cells maintained under 25 mM glucose condition, EB
embryoid body derived from E14 or GR-E14 cells, GR-E14 glucose-responsive E14 cell line, which was gradually adapted to 5 mM glucose medium from
25 mM glucose medium. All experiments were repeated three times (n = 3), the value was dedicated as mean ± SD. *Indicates significant difference
compared with the other group(s)








Fig. 2 (See legend on next page.)
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finding above, TNNT2-positive cells emerged at day 6 in 5
mM glucose, but were not present in 25 mM glucose
(Fig. 2h and i). Additionally, the TNNT2-positive cell
number in 25 mM glucose was significantly lower than
that in 5 mM glucose medium at day 8. 16.8 ± 1.5% of
TNNT2-positive cardiomyocytes were observed in 5 mM
glucose at day 10, whereas only 6.0 ± 3.1% of TNNT2-
positive cardiomyocytes were obtained in 25 mM glucose
medium. Collectively, these data demonstrate that high
glucose suppresses GR-E14 cell cardiogenesis.
To further confirm our finding, another mouse ES cell
line, D3, was adapted into low glucose and differentiated
into cardiomyocytes using the same method described
above. For the differentiation of D3 cells, contracting
EBs or cardiomyocytes appeared at day 7 in 5 mM glu-
cose and at day 9 in high glucose (25 mM) medium, re-
spectively (Fig. 2j, k). Thus, consistent with the
observation in GR-E14 cells (2d, e), high glucose delayed
D3 cell cardiogenesis for 2 days (Fig. 2d). 51.7 ± 3.1% of
the EBs were differentiated into contracting cardiomyo-
cytes in 5 mM glucose at day 10, whereas only 21.0 ±
1.6% contracting EBs were obtained under high glucose
(25 mM) conditions (Fig. 2j). Furthermore, the contract-
ing colonies ratio in 25 mM glucose was also signifi-
cantly lower than that in 5 mM glucose (Fig. 2k).
However, the differentiation efficiency of the D3 cell line
was lower than that of GR-E14 (Fig. 2d, j), the following
experiments were performed on GR-E14 cells only.
High glucose represses gene expression essential for
cardiogenesis
To determine whether high glucose affects the expres-
sion of early cardiac markers, we detected precardiac
mesoderm marker, Brachyury (T) and Mixl1, and heart
field-specific progenitor markers, NKX2.5, TBX5, and
GATA4. The expression of T and Mixl1 in 5 mM glucose
was significantly higher than that in high glucose (25 mM)
before day 5 of differentiation (Fig. 3a). More interestingly,
the expression of heart field-specific progenitor markers,
NKX2.5, TBX5, and GATA4, in 5 mM glucose was signifi-
cantly higher than that in high glucose (Fig. 3b). Specific-
ally, GATA4 expression in 5 mM glucose was significantly
higher than that in high glucose at the EB stage and
throughout the entire course of differentiation (Fig. 3b).
Furthermore, 45.4 ± 3.7% of NKX2.5-positive cells were
observed in 5 mM glucose; however, 26.4 ± 2.3% cells were
NKX2.5-positive in high glucose (Fig. 3c, d). TBX5 and
GATA4 protein levels were also suppressed by high glu-
cose (Fig. 3e). Thus, high glucose suppresses cardiac gene
expression during GR-E14 cardiogenesis.
High glucose inhibits the maturation of differentiated
cardiomyocytes
Because high glucose significantly decreased the number
of contracting cardiomyocytes, we next assessed the ex-
pression of mature cardiomyocyte markers, TNNT2 and
MEF2C, during differentiation of GR-E14 cells into cardi-
omyocytes. At day 7 of differentiation, MEF2C and
TNNT2 levels were significantly higher in 5 mM glucose
than those in high glucose (Fig. 4a). Coinciding with
mRNA expression, TNNT2 immunofluorescent staining
showed a significantly higher number of TNNT2-positive
cells in 5 mM glucose compared with high glucose (Fig. 4b,
c). Total cellular MEF2C and TNNT2 protein levels were
significantly reduced by high glucose (Fig. 4d).
These findings demonstrate that cardiomyocyte matur-
ation is attenuated by high glucose.
High glucose reduces the expression of potassium channel
proteins that are essential for cardiomyocyte contraction
Cardiomyocyte contracting function is highly associated
with calcium-handling process and several ion channels
(See figure on previous page.)
Fig. 2 High glucose suppresses GR-E14 cell cardiogenesis. a Schematic diagram of ES cell cardiomyocytes. Hanging-drop culture was performed
with one drop of 30 μl medium per 1000 cells for 3 days for EB formation, and then suspension culture was done in a 10-cm petri dish for
another 2 days for EB growth followed by differentiation. b The numbers of EB attached to the culture plate on day 1 after seeding the formed
EBs (differentiation). c The numbers of EB attached to the culture plate on day 5 of differentiation. GR-E14 cells adapted to low glucose were used
for hanging-drop culture in low glucose (5 mM, LG) or high glucose (25 mM) medium (LG2HG), parent E14 cells maintained in high glucose
medium were used for hanging-drop culture in HG or low glucose medium (HG2LG). d The percentage of contracting EBs in GR-E14 cells under
LG/HG condition. Fifty EBs per group (n = 3) were used for cardiogenesis and the contracting EB percentage was calculated by the formula: (number
of contracting EBs/number of total EBs) × 100%. e Numbers of contracting colonies from GR-E14 cells under LG/HG conditions. At day 5 of EB
formation, an aliquot of 10 μl EB suspension, containing 20 EBs (equivalent to 5 × 105 cells), was seeded into a well of a 6-well culture plate
for cardiogenesis. f Percentage of contracting colonies from GR-E14 cells under LG/HG conditions. The contracting colony percentage was
calculated by the formula: (number of contracting colonies/number of total colonies) × 100%. g Frequencies of contracting colonies from GR-E14
under LG/HG conditions. h The frequencies of TNNT2+ cardiomyocytes at day 6 (left), day 8 (middle) and day 10 (right) after differentiation. HG high
glucose (25 mM, red), LG low glucose (5 mM, gray),. i Percentages of TNNT2+ cardiomyocytes differentiated from GR-E14 cells. TNNT2+ cell percentages
(%) = (TNNT2+ cell number/total cell number) × 100%. Total cell number is 10,000 per group. j The percentage of contracting EBs in D3 cells under LG/
HG conditions. The protocol was the same as that of GR-E14. k Percentage of contracting colonies from D3 cells under LG/HG conditions. The protocol
was the same as that of GR-E14. E14 E14 cells maintained under 25 mM glucose condition, GR-E14 glucose-responsive E14 cell line, which was
gradually adapted to 5 mM glucose medium from 25 mM glucose medium. All experiments were repeated three times (n = 3). Data were
expressed as mean ± SD. *Indicate significant difference compared with the other group(s)
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[35, 36]. Among them, the hyperpolarization-activated
cyclic nucleotide-modulated (HCN) channels contribute
to a faster rhythmicity of beating mouse cardiomyocytes
derived from ES cells [37, 38]. To understand the im-
paired contraction of cardiomyocytes by high glucose,
we detected the expression of several ion channels
genes, including Cav1.2, Nav1.5, HCN1-4, KCN1, and
calcium-handling genes, SERCA2A and RYR2. High glu-
cose did not affect the expression of the two main
calcium-handling genes, SERCA2A and RYR2 (Fig. 5a).
However, the expression of the potassium channels,
HCN1 and KCN1, was significantly decreased by high
glucose beginning at day 5 of differentiation before on-
togeny of beating cardiomyocyte at day 6 (Fig. 5b).
Moreover, there are more HCN1-positive cells in 5 mM
than in high glucose (Fig. 5c and d). Total cellular KCN1
protein levels were significantly reduced by high glucose






Fig. 3 High glucose inhibits gene expression essential for cardiogenesis. a mRNA levels of mesodermal markers, T, and MIXL1 during GR-E14 cell
cardiogensis. b mRNA levels of cardiac transcription factors, NKX2.5, TBX5, and GATA4. c Representative images of NKX2.5 immunofluorescent
staining (green). DAPI (blue) was for cell nuclei staining. d Quantitative fluorescent density data of NKX2.5 immunofluorescent staining. e TBX5 and
GATA4 protein levels at differentiation day 7. Gene expression was assessed at EB formation day 5 and attachment culture (differentiation) at day
1, 3, 5, and 7. Experiments were repeated three times (n = 3). EB embryoid body derived from E14 or GR-E14 cells, HG high glucose (25 mM), LG
low glucose (5 mM). Values were dedicated as mean ± SD. *Indicates significant difference compared with the other group
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cardiomyocytes under high glucose condition was deter-
mined by Ca2+ wave profile. High glucose significantly
suppressed the frequency of Ca2+ wave in differentiated
cardiomyocytes (Fig. 5f and g). Consistent with the re-
duced Ca2+ wave frequency, high glucose inhibited the
contracting frequency of contracting colonies (Fig. 2g
and Additional file 2: Video 1, and Additional file 3:
Video 2). These results indicate that the decreased
potassium channel expression may contribute to the
impaired contraction of cardiomyocytes in high glucose.
Discussion
The precise temporal regulation of thousands of genes
that govern developmental decisions is required during
heart development [39]. However, gene expression pat-
terns during developmental transitions to cardiac lineage
are still not well understood. Cardiomyocyte differenti-
ation derived from ES cells is a widely used model for
studies in mimicking early cardiomyocyte development
in vivo. There is a number of robust protocols for ES cell
cardiogenesis including the EB hanging-drop method,
which have provided many pivotal clues for understand-
ing heart lineage specification [25]. Surprisingly, most ES
cell maintenance and differentiation conditions are at
high glucose conditions, often with 25 mM glucose [40].
High glucose may adversely impact ES cardiogenesis.
The effect of glucose on ES cell cardiogenesis has been





Fig. 4 High glucose suppresses cardiomyocyte-specific marker expression. a mRNA levels of cardiomyocyte structure proteins, MEF2C, and TNNT2.
b Representative images of TNNT2 immunofluorescent staining. c Quantitative fluorescent density data of TNNT2 immunofluorescent staining. d
MEF2C and TNNT2 protein expression at differentiation day 9. Gene expression was assessed at EB formation day 5 and differentiation day 1, 3, 5,
and 7. Experiments were repeated three times (n = 3). EB embryoid body derived from E14 or GR-E14 cells, HG high glucose (25 mM), LG low
glucose (5 mM). Values were dedicated as mean ± SD. *Indicates significant difference compared with the other group
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glucose supported ES cardiogenesis through reactive
oxygen species (ROS), whereas 5 mM glucose did not
generate any contracting cardiomyocytes [40]. However,
the ES cells in this previous study were generated and
maintained under high glucose and just adapted to low
glucose for a short time, two passages, prior to differen-
tiation [40]. Due to this short low glucose adaptation,
the ES cells may not acquire glucose responsiveness.
Indeed, they did not assess glucose responsiveness of ES
cells before differentiation [40]. Therefore, whether these
short-term low glucose-adapted cells responded to high
glucose was unknown. In contrast, we obtained an ES
cell line, GR-E14, which is adapted to low glucose condi-
tion through a 20 passage graduated glucose reduction,
and acquires glucose responsiveness before differenti-







Fig. 5 The inhibitory effect of high glucose on calcium-handling and potassium channel gene expression during GR-E14 cardiogenesis. a mRNA
levels of calcium-handling genes, SERCA2A and RYR2. b mRNA levels of potassium channel genes, HCN1 and KCN1. c Representative images of
HCN1 immunofluorescent staining (green). DAPI (blue) was for cell nuclei staining. d Quantitative fluorescent density data of HCN1 immunofluorescent
staining. e KCN1 protein expression at differentiation day 9. Gene expression was assessed at EB formation day 5 and differentiation day 1, 3, 5, and 7.
f Line scan image of fluo 4 in ES cell-derived cardiomyocytes in low or high glucose conditions. g Ca2+ wave frequency of ES-derived cardiomyocytes in
low or high glucose conditions. Experiments were repeated three times (n = 3). EB embryoid body derived from E14 or GR-E14 cells, HG high glucose
(25 mM), LG low glucose (5 mM). Values were dedicated as mean ± SD. *Indicates significant difference compared with the other group
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fashion without losing any stemness and pluripotency. A
recent report demonstrated that ES cells established
under low glucose condition possessed glucose respon-
siveness similar to cells of preimplantation and early
postimplantation embryos by manifesting high Glut2 ex-
pression [30]. The GR-E14 cell line also expresses high
levels of Glut2, implicating its glucose responsiveness.
Indeed, subsequent studies demonstrated that high glu-
cose adversely affected GR-E14 cardiogenesis.
The parent E14 cells accustomed to high glucose failed
to generate any contracting cardiomyocytes using the
hanging-drop method. It has been reported that ES cells
generated and maintained under high glucose conditions
can be differentiated into contracting cardiomyocytes
[28]. ES cell cardiogenesis depends on the differentiation
microenvironment [41], especially the starting ES cell
number, the volume of hanging drops as well as the time
of EB adherence to gelatin-coated plates [42]. The dis-
crepancy between our study and those of others may be
due to different settings of the hanging-drop method. In
Crespo’s study, ES cells were only passaged twice in low
(5 mM) glucose medium [40]. However, in the present
study, ES cells were passaged 20 times with gradually de-
creased glucose levels. GR-E14 cells were completely
adapted in low glucose conditions and had a high pluri-
potent potential. Second, the EB formation protocols be-
tween ours and Crespo’s were different. They performed
2 days of EB formation in hanging drop followed by ad-
hesion differentiation on gelatin-coated dishes. However,
5 days of EB formation protocol including 3 days hang-
ing drop and 2 days suspension culture were performed
in our study. Third, the hanging-drop settings were also
different. Settings of 1000 cells/30 μl/drop were used in
the present study for 3 days, whereas 1000 cells/20 μl/
drop were used in Crespo’s study for 2 days. All of these
differences may account for the discrepancy between the
two studies. Nevertheless, GR-E14 cells can be differenti-
ated into contracting cardiomyocyte at very high effi-
ciency and GR-E14 cell cardiogenesis is subjected to
glucose regulation, suggesting that our hanging-drop
method settings are ideal for studies in glucose regula-
tion of ES cell cardiogenesis. High glucose suppresses
GR-E14 cell cardiogenesis by delaying the ontogeny of
contracting EBs and reducing EB contraction frequen-
cies. Previous studies have shown that heart rates are
lower in the offspring of diabetic mothers than nondia-
betic mothers [43]. Thus, the GR-E14 cell line is a useful
in vitro model in mimicking the abnormal cardiogenesis
of embryos exposed to pregestational diabetes.
CHDs are the most common defects in offspring of
diabetic mothers [31]. Previous studies have shown that
gene dysregulation is critically involved in diabetes-
induced CHDs [13]. Our previous studies have deter-
mined that oxidative stress, endoplasmic reticulum
stress and pro-apoptotic kinase signaling mediate the
teratogenicity of diabetes in the developing heart by
modulating gene expression [4–6, 8]. To reveal the eti-
ology of diabetes-induced CHDs, it is critical to under-
stand the gene alterations during early cardiogenesis. A
highly conserved gene regulatory network controls the
initial differentiation, proliferation, and maturation of
cardiomyocytes [21]. The anteriorly migrated mesoderm
cells, once received appropriate signals, switch on a
highly conserved cardiac transcriptional program via se-
quentially expressing heart-specific transcription factors
[44]. Initially, Brachyury (T) and Mixl1-positive meso-
dermal precursor cells enter a precardiac mesoderm
stage as evidence of Mesp1 expression [45, 46]. Subse-
quently, Mesp1-positive cells begin to express NKX2.5
and TBX5, which combined with GATA4 to activate car-
diac structural genes such as TnnT2, MHC, and MLC
[44]. Any abnormalities in this cardiac specification pro-
gram result in CHDs. Mesodermal precursor cell
markers, T and Mixl1, were suppressed by high glucose
during early GR-E14 cardiogenesis. T deficiency in mice
resulted in early embryonic lethality due to defects in
mesoderm formation [47]. Mixl1 is required for axial
mesendoderm morphogenesis in differentiating ES cells
and murine embryos [48, 49]. Suppression of both T and
Mixl1 may be a primary cause of abnormality in GR-E14
cardiogenesis by high glucose. Nkx2.5, the earliest
known marker of the cardiac lineage in vertebrate em-
bryos, is expressed in mouse embryo from E7.5 onward
and its deletion causes CHDs resembling those in dia-
betic pregnancies [50, 51]. NKX2.5, TBX5, and GATA4
expression were suppressed by high glucose. Consistent
with the downregulation of these three cardiac transcrip-
tion factors, high glucose suppressed the expression of
mature cardiomyocyte markers, TNNT2 and MEF2C. In
human, mutation of TnnT2 is tightly associated with
hypertrophic cardiomyopathy, dilated cardiomyopathy,
and left ventricular noncompaction cardiomyopathy
[52–54]. Suppression of TnnT2 may contribute to im-
paired GR-E14 cardiogenesis under high glucose condi-
tion. These findings support the hypothesis that high
glucose adversely impacts the entire ES cardiogenesis pro-
gram. Our recent studies have demonstrated that cellular
stress including oxidative stress and endoplasmic
reticulum (ER) stress mediates the adverse effect of high
glucose in the developing heart [8, 9]. Future studies will
aim to determine whether cellular stress mediates the in-
hibitory effect of high glucose in ES cell cardiogenesis.
Intracellular Ca2+ is the central regulator of cardiac
contractility [55]. It is critically important how Ca2+ is
regulated during initiation of contraction of cardiomyo-
cyte under high glucose condition. In the present study,
some key regulation proteins in cardiac contractility, in-
cluding calcium, sodium, potassium channel proteins,
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and calcium in/outflux proteins (RYR2 and SERCA2A),
were investigated; however, most of these genes
expressed at similar levels under low and high glucose
conditions. Two potassium channel proteins, HCN1 and
KCN1, were suppressed by high glucose. In particularly
KCN1 was almost completely suppressed by high glu-
cose. The HCN1 protein is highly expressed in the sino-
atrial node and is colocalized with HCN4, the main
sinoatrial pacemaker channel isoform [56]. Therefore,
high glucose-suppressed HCN1 and KCN1 may contrib-
ute to reduced number of contracting cardiomyocytes
derived from GR-E14 cells. It is well known that intra-
cellular calcium release from the sarcoplasmic reticulum
is required for heart contraction [57]. Since high glucose
inhibited ES cell-derived cardiomyocytes contraction, it
is important to investigate the relationship between Ca2+
wave profile and contraction frequency. Interestingly, re-
duced frequency of Ca2+ wave profile under high glucose
condition was consistent with slower contraction fre-
quency in differentiated cardiomyocytes compared to
that in low glucose condition. These findings suggest
that the functionality of cardiomyocytes derived from ES
cells is impaired by high glucose.
Our finding indicated that high glucose inhibited GR-
E14 cell differentiation into cardiomyocytes. However
the underlying mechanism needs to be further eluci-
dated. Jang et al. reported that high glucose upregulated
ES cell pluripotency through elevated level of O-linked-
N-acetylglucosamine in proteins of core components of
the pluripotency network [58]. Furthermore, ES cells
utilize glucose catabolism to maintain a high level of
intracellular α-ketoglutarate, promoting histone/DNA
demethylation and pluripotency [59]. Therefore suppres-
sion of ES differentiation by high glucose may be due to
high glucose-increased pluripotency, which may ultim-
ately delay ES differentiation. Only one study indicates
that high glucose-induced reactive oxygen species (ROS)
promotes cardiomyocyte differentiation from ESC cells
[40]. Other studies have shown that high glucose en-
hances the expression of pluripotent markers, OCT4,
NANOG, and SOX2, in adipose-derived stem cells
through ROS generation [60, 61]. This indirect evidence
supports our conclusion that high glucose impairs ES
cell differentiation into cardiomyocytes.
Conclusions
GR-E14 cells adapted to physiological glucose acquire
glucose responsiveness. The GR-E14 cell line may be a
useful model for investigating the effect of high glucose
on early cardiac specification. Our study showed for the
first time that high glucose delayed and impaired GR-E14
cardiomyocytes by inhibiting early cardiac specification
genes, cardiac transcription factors, and genes essential
for cardiomyocyte maturation and contractility. Thus,
high glucose inhibits ES cardiogenesis by suppressing gene
expression. Our findings guide future ES maintenance and
differentiation by showing the adversity of high glucose in
ES cardiogenesis and providing the beneficial effects using
physiological concentration of glucose at 5 mM.
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